Edoxaban: all 75 studies that test it
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Edoxaban Versus Apixaban in Cancer-Associated Venous ThromboembolismNot yet recruitingNCT07852637Phase 4
- Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery DiseaseRecruitingNCT07753200Phase 4
- Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ TrialRecruitingNCT07454707Phase 3
- Edoxaban Steady-State PK/PD in Adults With Nephrotic SyndromeNot yet recruitingNCT07116239Not applicable
- Low Dose Edoxaban in Elderly Patients With AF and a History of StrokeNot yet recruitingNCT06900725Phase 2/3
- EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllationRecruitingNCT06285942Not applicable
- Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer PatientsNot yet recruitingNCT06149533Phase 3
- DOAC in Patients with Child a or B Liver CirrhosisRecruitingNCT05869591Phase 2
- Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral StenosisRecruitingNCT05540587Phase 2
- MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke PreventionRecruitingNCT03961334Phase 3
- Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial FibrillationRecruitingNCT03642509Not applicable
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)CompletedNCT03551743Phase 2Results posted
- Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac DiseaseCompletedNCT03395639Phase 3Results posted
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)CompletedNCT02943785Phase 3Results posted
- Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter AblationCompletedNCT02942576Phase 3Results posted
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionCompletedNCT02866175Phase 3Results posted
- Study of DU-176b Aged 80 Years or OlderCompletedNCT02801669Phase 3Results posted
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)CompletedNCT02798471Phase 3Results posted
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
- Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate EpisodesTerminatedNCT02618577Phase 3Results posted
- EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial FibrillationTerminatedNCT02561897Phase 4Results posted
- Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV DiseaseCompletedNCT02339415Phase 2Results posted
- Cancer Venous Thromboembolism (VTE)CompletedNCT02073682Phase 3Results posted
- Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)CompletedNCT02072434Phase 3Results posted
- Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal ImpairmentCompletedNCT01857622Phase 3Results posted
- Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower LimbsCompletedNCT01857583Phase 3Results posted
- Edoxaban in Peripheral Arterial DiseaseCompletedNCT01802775Phase 2Results posted
- A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein ThrombosisCompletedNCT01662908Phase 2Results posted
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
- A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
- A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01181167Phase 3Results posted
- Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture SurgeryCompletedNCT01181141Phase 3Results posted
- A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
- Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
- Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial FibrillationCompletedNCT00829933Phase 2Results posted
- DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial FibrillationCompletedNCT00806624Phase 2Results posted
- Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial FibrillationCompletedNCT00781391Phase 3Results posted
- A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial FibrillationCompletedNCT00504556Phase 2Results posted
- A Study of DU-176b in Preventing Blood Clots After Hip Replacement SurgeryCompletedNCT00398216Phase 2Results posted
- Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip ReplacementCompletedNCT00107900Phase 2Results posted
- A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of EdoxabanActive, not recruitingNCT07113054Phase 1
- The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNCT06449469Not applicable
- Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral AnticoagulantCompletedNCT06372483Phase 1
- PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy VolunteersCompletedNCT05723510Phase 1
- Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants SubjectsStatus unknownNCT05491460Phase 1
- Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial FibrillationCompletedNCT05320627Phase 4
- Effects of Edoxaban on Platelet AggregationCompletedNCT05122455Phase 2/3
- AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve ImplantationCompletedNCT05035277Phase 3
- Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)CompletedNCT04730037Phase 3
- Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"CompletedNCT04671316Phase 1
- CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19TerminatedNCT04516941Phase 3
- Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve ImplantationStatus unknownNCT04171726Phase 3
- Safety and Efficacy of Edoxaban in Thoracoscopic AblationCompletedNCT04121767Not applicable
- Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic TherapyCompletedNCT04072068Phase 4
- DOAC Versus VKA After Cardiac SurgeryWithdrawnNCT04002011Phase 2
- PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial FibrillationCompletedNCT03996772Phase 3
- EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)CompletedNCT03950076Phase 4
- Resolution of Thrombi in Left Atrial Appendage With EdoxabanCompletedNCT03840291Phase 4
- Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery DiseaseCompletedNCT03718559Phase 4
- NOAC Plasma Concentration and Blood Coagulation in Healthy VolunteersCompletedNCT03666650Phase 4
- Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)Status unknownNCT03570281Phase 2/3
- Lixiana Acute Stroke Evaluation RegistryCompletedNCT03494530Phase 4
- A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial FibrillationCompletedNCT03489395Phase 2
- Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial FibrillationCompletedNCT03433235Phase 2
- Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)CompletedNCT03244319Phase 3
- Start or STop Anticoagulants Randomised Trial (SoSTART)CompletedNCT03153150Phase 3
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)Active, not recruitingNCT03129555Phase 4
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial FibrillationActive, not recruitingNCT03129490Phase 4
- A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage ClosureStatus unknownNCT03088072Phase 4
- Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical OutcomesCompletedNCT02964949Not applicable
- ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)CompletedNCT02935855Phase 4
- Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and ClopidogrelCompletedNCT02567461Phase 4
- Edoxaban for TIA and Acute Minor StrokeStatus unknownNCT02221102Phase 2/3
- Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanCompletedNCT02207257Phase 2
- A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on AnticoagulationCompletedNCT02047565Phase 1